
| |  | |  |
Article
|
| Inhibition of Ape1 Nuclease Activity by Lead, Iron, and Cadmium Daniel R. McNeill, Avinash Narayana, Heng-Kuan Wong, and David M. Wilson
III Laboratory of Molecular Gerontology, Gerontology Research Center, National
Institute on Aging, Intramural Research Program, National Institutes of Health,
Department of Health and Human Services, Baltimore, Maryland, USA Abstract Many environmental metals are co-carcinogens, eliciting their effects via inhibition of DNA repair. Apurinic/apyrimidinic (AP) endonuclease 1 (Ape1) is the major mammalian abasic endonuclease and initiates repair of this cytotoxic/mutagenic lesion by incising the DNA backbone via a Mg2+-dependent reaction. In this study we examined the effects of arsenite [As(III) ], cadmium [Cd(II) ], cobalt [Co(II) ], iron [Fe(II) ], nickel [Ni(II) ], and lead [Pb(II) ] at concentrations ranging from 0.3 to 100 µM on the incision activity of Ape1 in the presence of 1 mM MgCl2. Pb(II) and Fe(II) inhibited Ape1 activity at each of the concentrations tested, with an IC50 (half-maximal inhibitory concentration) of 0.61 and 1.0 µM, respectively. Cd(II) also inhibited Ape1 activity but only at concentrations > 10 µM. No inhibition was seen with As(III) , Co(II) , or Ni(II) . A similar inhibition pattern was observed with the homologous Escherichia coli protein, exonuclease III, but no inhibition was seen with the structurally distinct AP endonuclease E. coli endonuclease IV, indicating a targeted effect of Pb(II) , Fe(II) , and Cd(II) on the Ape1-like repair enzymes. Excess nonspecific DNA did not abrogate the metal inactivation, suggesting a protein-specific effect. Notably, Cd(II) , Fe(II) , and Pb(II) [but not As(III) , Co(II) , or Ni(II) ] inhibited AP endonuclease activity in whole-cell extracts but had no significant effect on single nucleotide gap filling, 5´-flap endonuclease, and nick ligation activities, supporting the idea of selective inactivation of Ape1 in cells. Our results are the first to identify a potential DNA repair enzyme target for lead and suggest a means by which these prevalent environmental metals may elicit their deleterious effects. Key words: Ape1 AP endonuclease, base excision DNA repair, environmental heavy metal toxicity, lead, mutagenesis/carcinogenesis. Environ Health Perspect 112:799-804 (2004) . doi:10.1289/txg.7038 available via http://dx.doi.org/ [Online 13 April 2004] Address correspondence to D. Wilson, Laboratory of Molecular Gerontology, GRC, National Institute on Aging, IRP, NIH, 5600 Nathan Shock Dr., Baltimore, MD 21224-6825. Telephone: (410) 558-8153. Fax: (410) 558-8157. E-mail: wilsonda@grc.nia.nih.gov We thank E. Silbergeld (Johns Hopkins Bloomberg School of Public Health) , V. Bohr and R. Brosh (NIA) , P. Ellis (Pacific Northwest National Laboratory) , and J. Carney (University of Maryland School of Medicine) for critical reading and helpful discussion of this manuscript. The authors declare they have no competing financial interests. Received 17 February 2004 ; accepted 13 April 2004. |
|
|
 |
Toxic metal compounds are widely distributed in the environment and are frequently
used in industrial processes (Hayes 1997). Because of their extended persistence
in biological systems and their tendency to accumulate in certain tissues,
they represent important environmental and occupational hazards. Epidemiologic
studies and animal trials have shown many metal compounds to be carcinogenic,
although they elicit only mild mutagenic effects in bacterial test systems
or in mammalian cell culture (Hartwig et al. 2002; Hartwig and Schwerdtle 2002).
DNA repair systems function to correct DNA damage that arises spontaneously
or due to exposure to certain environmental agents (Hoeijmakers 2001). It is
well documented that reduced DNA repair capacity can lead to genetic instability
and thus human disease, most notably cancer. Because cell biology studies indicate
that many metal compounds enhance the genotoxic effects of known mutagens such
as ultraviolet C radiation, X rays, benzo[a]pyrene, cisplatin, and DNA
alkylating agents, it has been postulated that environmental metals are comutagenic
and potentiate the carcinogenic effects of DNA-damaging agents by inhibiting
DNA repair processes (Hartwig et al. 2002; Hartwig and Schwerdtle 2002; Hayes
1997). Consistent with this notion, both in vitro and in vivo studies
have shown that certain metal compounds can inhibit specific DNA repair events.
For example, Cd(II), Cu(II), Co(II), and Ni(II) inhibit (at concentrations 200 µM) the in vitro DNA-binding activity of the human xeroderma
pigmentosum group A protein, a critical damage recognition factor in nucleotide
excision repair (Asmuss et al. 2000). Poly(adenosine diphosphate-ribose)polymerase
1, which operates as a molecular sensor in DNA strand-break responses, is inactivated
by Ni(II), Co(II), Cd(II), Cu(II), and very low concentrations (10 nM) of As(III)
(Hartwig et al. 2003). The DNA-binding capacity of the tumor suppressor protein
p53 is impaired by Cd(II), Ni(II), and Co(II) (Meplan et al. 1999; Palecek
et al. 1999). In addition, Cd(II) and Zn(II) (at 100 µM) inactivate
the in vitro DNA glycosylase activity of Ogg1, a mammalian repair enzyme
that functions to excise damaged/mutagenic bases, such as 8-oxoguanine, from
DNA (Zharkov and Rosenquist 2002).
Cd(II) was recently shown to inhibit DNA mismatch repair (MMR) (Jin et al.
2003), a process known to correct replication errors; deficiencies in this
pathway have been linked to the development of hereditary nonpolyposis colorectal
cancer (Heinen et al. 2002). Although the precise target for MMR inhibition
remains unclear, Jin et al. (2003) found that yeast chronically exposed to
environmental concentrations of Cd(II) display an increased mutation rate genetically
dependent on an intact MMR pathway. Thus, studies are beginning to unveil the
molecular targets of environmental metals and the mechanisms by which they
may elicit their co-mutagenic effects and, hence, carcinogenic potential.
Apurinic/apyrimidinic (AP) sites are frequent lesions in DNA, generated by
spontaneous, damage-induced, or enzyme-catalyzed hydrolysis of the N-glycosylic
bond, which attaches the base moiety to the sugar residue (Wilson and Barsky
2001). If unrepaired, these noncoding lesions present both cytoxic and mutagenic
challenges to the cell. AP endonuclease 1 (Ape1) is the major mammalian abasic
endonuclease, accounting for > 95% of the total cellular AP site incision
activity (Demple and Harrison 1994). This enzyme initiates repair of AP sites
by cleaving the phosphodiester backbone 5´ to the damage site, a critical
step in the base excision repair (BER) pathway, which handles most spontaneous,
alkylation, and oxidative DNA damage (Kelley et al. 2003). In addition to its
role as an AP endonuclease, Ape1 functions in specific strand-break contexts
to excise 3´-oxidative blocking termini (e.g., phosphoglycolate and phosphate
damages) (Suh et al. 1997; Wilson 2003; Winters et al. 1994), as well as certain
3´-mismatched nucleotides (Chou and Cheng 2002; Hadi et al. 2002), via
its 3´- to 5´-phosphodiesterase/exonuclease activity. Each of these
Ape1 repair functions is carried out by the same metal (magnesium)-dependent
catalytic reaction (Gorman et al. 1997; Mol et al. 2000b).
Animal studies have shown that heterozygous (reduced-function) APE1 mice,
which maintain 50% Ape1 repair activity, exhibit increased risk for phenotypic
consequences associated with oxidative stress, most notably reduced survival
and elevated cancer susceptibility (Meira et al. 2001). Because both X-ray
crystallography and nuclear magnetic resonance (NMR) spectroscopy studies revealed
that lead can bind the active site of Ape1 (Beernink et al. 2001; Lowry et
al. 2003), we explored the effects of several heavy metals, at presumed biological
concentrations, on Ape1 DNA repair function. In this article, we demonstrate
that Pb(II) and Fe(II), and to a lesser degree Cd(II), inhibit Ape1 nuclease
activity, unveiling a novel molecular target for these environmental metals.
Materials and Methods
Reagents
|
Figure 1. Oligonucleotide substrates. C, cytosine;
comp, complementary
DNA; F, tetrahydrofuran; G, guanine; GFT, guanine-tetrahydrofuran-
thymine-containing
26-mer oligonucleotide; nt, nucleotide; OH, hydroxyl; P, phosphate. Numbers indicate
oliogonucleotide length. (A) Nucleotide sequence of the 26-mer AP-DNA
duplex and the chemical composition of the synthetic abasic residue. F represents
the abasic site analog tetrahydrofuran. (B) Schematic of the oligonucleotide
substrates used to measure AP endonuclease (AP-DNA), 1-nt gap-filling (1-nt
gap), 5´-flap endonuclease (flap), and nick ligation (nick) activities.
Further details of
these substrates can be found in A or Wilson 2003). The position of the
radiolabel is indicated by the asterisk. The nucleotide sequence of 34(10)flap
is as follows: 5´-GGTAGGTAAACG
TACGGATCCCCGGGTAC-3´.
|
Figure
2. Effects of environmental metals on Ape1 incision activity. Abbreviations:
NE, no enzyme control; E, enzyme + 1 mM MgCl2, but no environmental
metal; S, substrate; P, product. (A) Ape1 incision activity
after exposure to As(III), Cd(II), Co(II), Fe(II), Ni(II), or Pb(II).
Ape1 activity was monitored
as described in "Materials and Methods." Notes (data not shown): Hydrochloric
acid, which was used to dissolve the iron, had no effect (< 12%) on Ape1 incision
activity at the highest concentration employed (100 µM). Ape1 exhibited
an identical incision efficiency in MgCl2- and MgAc-containing reaction
buffers, indicating that the effects seen were the result of the lead ion and
not the acetate. Moreover, lead acetate, when added to either MgCl2-
or MgAc-containing reactions, inhibited Ape1 incision activity. (B) Graphical
presentation of the metal ion effects on Ape1 incision activity. Relative incision
activity is based on a percentage comparison between the enzyme-only control
standard incision and the individual incision reaction of interest. Values shown
are relative Ape1 incision activities, normalized to the 0 µM, no environmental
metal control (listed here as 100), and represent the average and standard deviation
of at least three independent data points. Concentration of the environmental
metals is indicated. |
|
Figure 3. Effects of environmental metals on ExoIII
(A) and EndoIV
(B) AP site incision activity. Abbreviations: E, enzyme alone; NE, no
enzyme control; P, product; S, substrate. In both panels a representative gel
image (top) and the quantitative numbers (bottom) are shown. Relative incision
activity is based on a percentage comparison between the enzyme-only control
standard incision and the individual incision reaction of interest. Relative
incision activities are normalized to the 0-µM no environmental control
(listed here as 100) and represent the average of at least three independent
data points. See "Materials and Methods" for details. Standard error for the
values shown was ± 11%.
|
Figure 4. Heavy metal inhibition is not abrogated by nonspecific
duplex DNA. Abbreviations: E, enzyme alone; NE, no enzyme control.
(A) Competitor DNA does not affect lead inhibition. Ape1 is
incubated without (E or -) or with lead (+, Pb), and then no (-),
0.1 pmol, or 1 pmol of nonspecific DNA (Comp) is added with radiolabeled
F-DNA (0.1 pmol). The ability of Ape1 to convert substrate (S) to product
(P) is then evaluated as described in "Materials and Methods." (B)
Quantitation of competitor and lead effects on Ape1 incision activity.
Relative incision activity is based on a percentage comparison between
the enzyme-only control standard incision and the individual incision
reaction of interest. Relative
incision activity (y-axis) is shown, with standard deviations, for the
six reaction conditions denoted in A and B (1-6). 1 = enzyme
(E) control; 2 = Ape1 + 0.1 pmol competitor DNA; 3 = Ape1 + 1 pmol competitor;
4 = Ape1 + 10 µM Pb(II); 5 = Ape1 + 10 µM Pb(II) + 0.1 pmol competitor;
6 = Ape1 + 10 µM
Pb(II) + 1 pmol competitor.
|
Figure 5. Metal inhibition in whole-cell extract assays. Abbreviations:
E , enzyme alone; NE, no enzyme control; P, product; S, substrate.
(A) Cd(II), Fe(II), and Pb(II) selectively inactivate total
AP endonuclease activity. Whole-cell extracts were prepared, and the
indicated DNA metabolic activity was measured in the presence or absence
of the noted heavy metal as described in "Materials and Methods." See
Figure 1B for substrates. For gap filling, single nucleotide extension
of the 5´-end-labeled 15P primer was monitored. For flap endonuclease
activity, conversion of the 29-mer 34(10)flap oligonucleotide to a
10-mer DNA product was examined. Nick ligation was measured by determining
the conversion of the radiolabeled 15P oligonucleotide to the full-length,
ligated 34-mer (or its 33 nucleotide degradation product). The two
products in the nick ligation assays presumably arise from ligation,
followed by 3´- to 5´-exonuclease
degradation. (B) Graphical presentation of the metal ion effects on the
various metabolic activities. Values shown are relative activities, compared
with the 0 µM, no environmental metal control (designated 100), and represent
the average and standard deviation of at least three independent data points.
Concentration of the environmental metals (indicated) was 100 µM.
|
Recombinant, untagged human Ape1, Escherichia coli exonuclease III
(ExoIII), and E. coli endonuclease IV (EndoIV) proteins were purified
essentially as described (Erzberger et al. 1998). DNA oligonucleotides were
obtained from The Midland Certified Reagent Company (Midland, TX) [see Figure
1 and Wilson (2003) for details]. All heavy metal compounds were purchased
from Sigma-Aldrich (St. Louis, MO). Denaturing polyacrylamide gel materials
were obtained from National Diagnostics (Atlanta, GA).
Ape1 Nuclease Assays
Ape1 incision activity was monitored essentially as described (Wilson et
al. 1995). Briefly, the tetrahydrofuran (F)-containing oligonucleotide was
5´-32P-end labeling and annealed to the complementary DNA (see
Figure 1A for nucleotide sequences). AP endonuclease reactions (unless otherwise
instructed) consisted of the following: 50 mM Hepes, pH 7.5; 100 mM KCl; 1
mM MgCl2; 200 pg (0.56 nM, assuming a molecular weight of 35,555
g/mol) Ape1, and either 0, 0.3, 1, 3, 10, 30, or 100 µM As(III), Cd(II),
Co(II), Fe(II), Ni(II), or Pb(II) (as indicated) in a final volume of 10 µL.
After a 10-min incubation on ice, 1 pmol labeled DNA substrate was added. Incision
reactions were performed at 37°C for 10 min, stopped by the addition of
10 µL formamide buffer, and analyzed by electrophoresis on an 18% denaturing
polyacrylamide gel. AP endonuclease activity is the amount of starting radiolabeled
tetrahydrofuran containing DNA (F-DNA) substrate converted to the shorter incised
DNA product in 10 min. Percent conversion was determined using standard Molecular
Dynamics phosphorimager analysis and ImageQuant, version 5.2, software (Amersham
Biosciences Corp., Piscataway, NJ).
For the nonspecific competitor DNA assays, everything was identical except
labeled F-DNA and Ape1 were present at 0.1 pmol and 50 pg, respectively. After
incubation of Ape1 with the metal ion, F-DNA was added with either 0.1 or 1
pmol of undamaged, duplex (26-mer) competitor DNA. Incision reactions were
performed immediately, and the samples were analyzed as indicated above.
Endonuclease IV/Exonuclease III Assays
EndoIV reactions consisted of 100 mM Hepes, pH 7.5; 100 mM KCl; 20% glycerol;
0.02% TX-100; 1 ng (3.2 nM, assuming a molecular weight of 31,480 g/mol) EndoIV,
and 100 µM of the indicated metals in 10 µL. ExoIII reactions consisted
of 50 mM Hepes, pH 7.5; 100 mM KCl; 1 mM MgCl2; 1 ng (3.2 nM, assuming
a molecular weight of 30,969 g/mol) ExoIII, and 100 µM of the appropriate
metals (as indicated) in 10 µL. DNA substrate (1 pmol) was added after
a 10-min incubation on ice, and the incision efficiency was determined as for
Ape1 (see above).
Whole-Cell Extract Assays
293T cells (80% confluent) were trypsinized and washed with phosphate-buffered
saline. The cells were then frozen at -80°C for 1 hr before cell
extract production. Cells were resuspended in 1 mL lysis buffer (50 mM Tris,
pH 7.4, 1 mM EDTA, 1 mM DTT, 10% glycerol, 0.5 mM PMS) and sonicated, and a
Bradford assay was run to determine the protein concentration of the supernatant
(whole-cell extract).
AP endonuclease, single nucleotide (nt) gap-filling, 5´-flap endonuclease,
and nick ligation activities were determined using the oligonucleotide substrates
described in Figure 1B. For the first three activities, reaction conditions
were the same as that used in the Ape1 assays above. The gap-filling reaction
also included 100 µM dCTP to monitor nucleotide incorporation. One microgram
of whole-cell extract was used to measure AP endonuclease activity, 10 µg
for flap endonuclease activity, and 20 µg for gap-filling activity, in
a final volume of 10 µL. Nick ligation reactions consisted of 60 mM Tris-HCl,
pH 8.0; 10 mM MgCl2; 1 mM DTT; 50 µg/mL BSA; 1 mM ATP; and
30 µg cell extract in a final volume of 20 µL. Whole-cell extracts
were incubated (where indicated) for 10 min on ice with 100 µM As(III),
Cd(II), Co(II), Fe(II), Ni(II), or Pb(II). After incubation, 1 pmol of the
appropriate DNA substrate was added, and reactions were performed as follows:
AP endonuclease, gap-filling, and flap endonuclease activities for 10 min at
37°C; and nick ligation assays for 30 min at room temperature. The percentage
of substrate converted to product was determined after denaturing polyacrylamide
gel electrophoresis using standard phosphorimager analysis as above.
Results
Inhibition of Ape1 Nuclease Activities by Lead, Iron, and Cadmium
Using a 26-mer oligonucleotide duplex containing a single, centrally located
abasic site analog--the F residue (Figure 1A)--we assessed the effects of several
common environmental metals on Ape1 incision capacity. In brief, Ape1 was incubated
in reaction buffer containing 1 mM MgCl2 with 0, 0.3, 1, 3, 10,
30, or 100 µM As(III), Cd(II), Co(II), Fe(II), Ni(II), or Pb(II). After
incubation on ice for 10 min, 32P-labeled double-stranded F-DNA
was added, and the ability of Ape1 to convert the longer AP site-containing
DNA strand to a shorter oligonucleotide product was evaluated. As shown in
Figure 2, Pb(II) and Fe(II) quantitatively exhibited the most pronounced inhibitory
effects on Ape1 endonuclease activity in a concentration-dependent manner.
Cd(II) also demonstrated an inhibitory effect, but only at the higher concentrations
examined (starting at 10 µM). None of the other divalent metal compounds
[i.e., As(III), Co(II), and Ni(II)] had a profound impact on Ape1 incision
activity (Figure 2). Using the double reciprocal plot method of Porter et al.
(1997), IC50 values for Cd(II), Fe(II), and Pb(II) were determined
to be 26, 1.0, and 0.61 µM, respectively.
To explore whether the metal inhibition observed was universal to Ape1 nuclease
activity, we examined the impact of the environmental metals on Ape1 3´-
to 5´-exonuclease function (Wilson 2003). As anticipated, Ape1 exonuclease
activity on a 1 nt gap substrate was similarly inhibited by Fe(II), Pb(II),
and Cd(II), with no significant effect seen with the other metals (data not
shown), suggesting a general (substrate-independent) inactivation of Ape1 catalytic
activities.
Specific Inhibition of the Ape1-like Repair Proteins
In E. coli there are two major AP endonuclease proteins, ExoIII and
EndoIV (Demple and Harrison 1994). These proteins represent distinct families,
as there is no primary amino acid sequence or structural homology between them
(Mol et al. 2000a). Ape1 is a functional and structural homolog of ExoIII and
belongs to this family of abasic endonucleases. To explore potential conservation
of the metal-dependent inhibition seen with human Ape1, we examined the effects
of As(III), Cd(II), Co(II), Fe(II), Ni(II), and Pb(II) on the AP site incision
activity of the bacterial endonucleases (Figure 3). As anticipated, E. coli ExoIII
showed a pattern of divalent metal inhibition similar to that observed with
the Ape1 protein. Conversely, EndoIV was unaffected by the presence of any
of the environmental metals. These results indicate a selective inhibition
of the related ExoIII and Ape1 proteins by Cd(II), Fe(II), and Pb(II) and argue
against an indirect (or nonspecific) effect of these metals.
Protein-Specific Inactivation
To further evaluate the specificity of the observed metal-dependent inactivation
(Figure 2), addressing in particular whether the heavy metals simply electroplate
DNA (i.e., bind along the phosphodiester DNA backbone) and interfere with Ape1
function indirectly, we examined the effects of Cd(II), Fe(II), and Pb(II)
in the presence or absence of undamaged, nonspecific (chelating) DNA. Briefly,
after incubation of Ape1 protein with an inhibitory metal, equimolar or 10-fold
excess nonspecific competitor DNA (relative to the labeled F-DNA) was added
simultaneously with radiolabeled abasic DNA substrate, and AP site incision
was then measured. These studies revealed that undamaged DNA alone (i.e., in
the absence of the heavy metal lead) had little (at 100 fmol) or a more significant
(at 1 pmol) effect on Ape1 endonuclease activity (Figure 4). Regardless, nonspecific
DNA did not abrogate the inhibitory effect of Pb(II) (Figure 4), suggesting
that metal inactivation was protein-specific, consistent with the conclusion
of the bacterial endonuclease studies presented above. Similar findings were
obtained with Cd(II) and Fe(II) (data not shown).
Specificity of Metal Inhibition in Whole-Cell Extracts
To more broadly assess the specificity of (and the effects of nonspecific
proteins on) the metal-dependent inhibition reported above, we determined the
impact of As(III), Cd(II), Co(II), Fe(II), Ni(II), and Pb(II) on AP endonuclease,
1 nt gap polymerase fill-in, 5´-flap structure-specific endonuclease,
and nick ligation activities in whole-cell extracts (see substrates depicted
in Figure 1B and assays described in Figure 5 legend). We reasoned that whole-cell
extracts would better mimic the in vivo environment, as they contain
a representative mix of proteins. We examined the above enzymatic activities,
as they are central to many DNA metabolic processes, including BER (Kelley
et al. 2003). As shown in Figure 5, only AP endonuclease activity was markedly
inactivated by Cd(II), Fe(II), and Pb(II). This finding emphasizes that these
heavy metals do not simply display universal, nonspecific inhibition of enzymatic
processes and may suggest that Ape1 (which comprises > 95% of the total
cellular AP site incision activity) (Demple et al. 1991) is selectively inactivated
by Cd(II), Fe(II), and Pb(II) in vivo.
Discussion
We demonstrate here that Cd(II), Fe(II), and Pb(II), three potential carcinogens
(Huang 2003; Silbergeld 2003; Waalkes 2003; Waisberg et al. 2003), can selectively
inactivate Ape1 repair activity in vitro (Figure 2), with IC50 (half-maximal
inhibitory concentration) values of 26, 1.0, and 0.61 µM, respectively.
To our knowledge, whereas Cd(II) has been shown to inhibit a number of DNA
repair enzymes, our studies are the first to identify a specific DNA repair
protein target for lead. Because of their accumulation in the choroid plexus
(the blood-cerebrospinal fluid barrier), cadmium and lead have also been
connected with neurotoxicity and neurological disorders, which are often associated
with elevated oxidative stress and/or inefficient repair responses (Zheng 2001).
Although Fe(II) is thought to elicit most of its deleterious impact via metal-catalyzed
free radical production (Kasprzak 2002), a concomitant inhibition of a key
oxidative DNA repair protein such as Ape1 could potentiate its harmful effects.
Iron is rarely found in the environment in a +2 state; however, Fe(II) can
accumulate in a mobile or labile form during conditions of iron overload or
after disruption of cellular homeostasis. Notably, iron misregulation (or overload)
in the brain plays an important role in neuronal death in some neurodegenerative
disorders, such as Alzheimer, Parkinson, and Huntington disease, as well as
Hallervorden-Spatz syndrome (Ke and Ming 2003). In total, evidence suggests
that certain environmental metals elicit their carcinogenic and/or neurodestructive
effects by inducing oxidative damage (particularly true for iron via the Fenton
reaction) and inhibiting repair processes (Hartwig et al. 2002; Hartwig and
Schwerdtle 2002; Hayes 1997; Kasprzak 2002).
Pb(II) levels have been observed at > 20 µg/dL (or ~0.6 µM)
in the blood of health-impaired individuals (Silbergeld 2003) and as high as
1-10 µM in certain occupationally exposed workers (Hayes 1997). If
a comparable concentration is attained in cells, then based on the IC50 value
of Pb(II), 50% of Ape1 activity would be inhibited. It is noteworthy
that a majority of the intracellular lead has been found in the nucleus (Hitzfeld
and Taylor 1989). For Cd(II) the amount of free metal is normally thought to
be negligible because of its very high affinity for metallothioneins. However,
cadmium ions may be transferred from one protein to another by exchange reactions
if relative affinities permit (Klaassen et al. 1999). During conditions of
oxidative stress, free Cd(II) levels may reach in vivo concentrations
in the millimolar range (Zharkov and Rosenquist 2002). Intracellular iron is
either tightly bound within iron-containing proteins (e.g., those factors with
iron-sulfur centers) or more transiently associated with low-molecular-weight
(LMW) ligands (Huang 2003). In these latter complexes, iron is easily exchangeable
and thus bioavailable for its essential functions as well as adverse effects,
including metal-catalyzed free radical production and promiscuous enzyme binding.
The estimated concentration of iron bound to the LMW ligands (the so-called
chelatable iron) is 1-10 µM in rodent and human cells (Petrat et
al. 2002). Given the metal concentrations at which Ape1 activity is inhibited
(excluding localized accumulation) and the selective inactivation seen in cell
extracts (Figure 5), it seems reasonable to conclude that Cd(II), Fe(II), and
Pb(II) may promote their harmful effects through inhibition of Ape1 repair
function.
Significantly, both Cd(II) and Pb(II) display co-genotoxic effects when combined
with methyl methanesulfonate, N-methyl-N-nitrosourea, or N-methyl-N´-nitro-N-nitrosoguanidine,
alkylating agents that generate significant levels of BER-type DNA intermediates,
including abasic lesions (Fatur et al. 2003; Hartwig 1994; Roy and Rossman
1992). Thus, because reduced Ape1 repair capacity (of 50%) has been correlated
with survival and cancer proneness (Meira et al. 2001), we postulate that certain
environmental metals such as Cd(II), Fe(II), and Pb(II) elicit their co-mutagenic
effects in part by inactivating (or depleting) Ape1 repair activities. In support
of the idea of targeted inhibition of Ape1 in vivo, we found that Cd(II),
Fe(II), and Pb(II) [but not As(III), Co(II), or Ni(II)] specifically inhibited
AP endonuclease activity in whole-cell extracts but did not dramatically affect
other steps of repair, such as single nucleotide gapfilling, 5´-flap endonuclease,
and nick ligation activities (Figure 5). These findings also speak to the selectivity
of these heavy metals for the Ape1 repair protein in the context of a protein
milieu. Cellular strategies are now being devised--keeping in mind the direct
DNA-damaging (oxidizing) effects of certain environmental metals (Hayes 1997;
Kasprzak 2002) and the apparent requirement of Ape1 for viability (Ludwig et
al. 1998; Meira et al. 2001; Xanthoudakis et al. 1996)--to evaluate whether
the metal-induced cytotoxic and/or mutagenic outcomes noted above are at least
in part Ape1 dependent.
Most transition metals bind acidic, sulfhydryl, or histidine residues within
target proteins. Lead, in particular, exhibits high affinity for Cys-His
zinc-binding motifs (Silbergeld 2003). Although we cannot state with certainty
the mechanism by which Cd(II), Fe(II), or Pb(II) [three metals that have divergent
coordination chemistries and different ligand preferences (Lippard and Berg
1994)] inactivates Ape1, both X-ray crystallography and NMR spectroscopy studies
found that lead can occupy two potential divalent metal binding sites within
the Ape1 active site (Beernink et al. 2001; Lowry et al. 2003). In particular,
lead associates with residues in Ape1 essential for enzymatic activity, most
notably His309, in a manner distinct from that seen with zinc-binding proteins.
Current evidence therefore suggests that inactivation of Ape1 is mediated by
a unique and specific interaction of the inhibitory metal with conserved active
site residues that in turn disrupts the metal-dependent (magnesium-dependent)
catalytic reaction. Consistent with this notion, Ape1 and the homologous ExoIII
protein exhibit a similar metal-dependent inactivation profile, whereas the
structurally distinct AP endonuclease EndoIV was not affected (compare Figures
2 and 3), implying a conserved and targeted effect of Cd(II), Fe(II), and Pb(II)
on the Ape1-like repair proteins. Furthermore, competition assays using nonspecific
DNA argue against an indirect effect of the metal ions, such as electroplating
of DNA (Figure 4), and suggest a protein-specific event. Finally, Ape1 DNA
binding was not dramatically altered by the presence of the various heavy metals
[excluding Fe(II), where a smear was observed] in gel mobility shift assays
(unpublished observations), suggesting disruption of the enzymatic step specifically.
While detailed structure-function studies are under way to precisely define
the mechanism of inhibition, the experiments here suggest a novel means by
which these prevalent environmental metals may elicit their harmful physiological
effects. |
|
 |
| [References Listed in PubMed] References
Asmuss M, Mullenders LH, Eker A, Hartwig A. 2000. Differential effects
of toxic metal compounds on the activities of Fpg and XPA, two zinc finger
proteins involved in DNA repair. Carcinogenesis 21:2097-2104.
Beernink PT, Segelke BW, Hadi MZ, Erzberger JP, Wilson DM III, Rupp B.
2001. Two divalent metal ions in the active site of a new crystal form of
human apurinic/apyrimidinic endonuclease, Ape1: implications for the catalytic
mechanism. J Mol Biol 307:1023-1034.
Chou KM, Cheng YC. 2002. An exonucleolytic activity of human apurinic/apyrimidinic
endonuclease on 3' mispaired DNA. Nature 415:655-659.
Demple B, Harrison L. 1994. Repair of oxidative damage to DNA: enzymology
and biology. Annu Rev Biochem 63:915-948.
Demple B, Herman T, Chen DS. 1991. Cloning and expression of APE, the
cDNA encoding the major human apurinic endonuclease: definition of a family
of DNA repair enzymes. Proc Natl Acad Sci USA 88:11450-11454.
Erzberger JP, Barsky D, Scharer OD, Colvin ME, Wilson DM III. 1998. Elements
in abasic site recognition by the major human and Escherichia coli apurinic/apyrimidinic
endonucleases. Nucleic Acids Res 26:2771-2778.
Fatur T, Lah TT, Filipic M. 2003. Cadmium inhibits repair of UV-, methyl
methanesulfonate- and N-methyl-N-nitrosourea-induced DNA damage
in Chinese hamster ovary cells. Mutat Res 529:109-116.
Gorman MA, Morera S, Rothwell DG, de La FE, Mol CD, Tainer JA, et al.
1997. The crystal structure of the human DNA repair endonuclease HAP1 suggests
the recognition of extra-helical deoxyribose at DNA abasic sites. EMBO J
16:6548-6558.
Hadi MZ, Ginalski K, Nguyen LH, Wilson DM III. 2002. Determinants in nuclease
specificity of Ape1 and Ape2, human homologues of Escherichia coli exonuclease
III. J Mol Biol 316:853-866.
Hartwig A. 1994. Role of DNA repair inhibition in lead- and cadmium-induced
genotoxicity: a review. Environ Health Perspect 102(suppl 3):45-50.
Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, et al.
2002. Interference by toxic metal ions with DNA repair processes and cell
cycle control: molecular mechanisms. Environ Health Perspect 110(suppl 5):797-799.
Hartwig A, Pelzer A, Asmuss M, Burkle A. 2003. Very low concentrations
of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells. Int J Cancer
104:1-6.
Hartwig A, Schwerdtle T. 2002. Interactions by carcinogenic metal compounds
with DNA repair processes: toxicological implications. Toxicol Lett 127:47-54.
Hayes RB. 1997. The carcinogenicity of metals in humans. Cancer Causes
Control 8:371-385.
Heinen CD, Schmutte C, Fishel R. 2002. DNA repair and tumorigenesis: lessons
from hereditary cancer syndromes. Cancer Biol Ther 1:477-485.
Hitzfeld B, Taylor DM. 1989. Characteristics of lead adaptation in a rat
kidney cell line. I. Uptake and subcellular and subnuclear distribution of
lead. Mol Toxicol 2:151-162.
Hoeijmakers JH. 2001. Genome maintenance mechanisms for preventing cancer.
Nature 411:366-374.
Huang X. 2003. Iron overload and its association with cancer risk in humans:
evidence for iron as a carcinogenic metal. Mutat Res 533:153-171.
Jin YH, Clark AB, Slebos RJ, Al Refai H, Taylor JA, Kunkel TA, et al.
2003. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat Genet
34:326-329.
Kasprzak KS. 2002. Oxidative DNA and protein damage in metal-induced toxicity
and carcinogenesis. Free Radic Biol Med 32:958-967.
Ke Y, Ming QZ. 2003. Iron misregulation in the brain: a primary cause
of neurodegenerative disorders. Lancet Neurol 2:246-253.
Kelley MR, Kow YW, Wilson DM III. 2003. Disparity between DNA base excision
repair in yeast and mammals: translational implications. Cancer Res 63:549-554.
Klaassen CD, Liu J, Choudhuri S. 1999. Metallothionein: an intracellular
protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39:267-294.
Lippard SJ, Berg JM. 1994. Principles of Bioinorganic Chemistry. Herndon,
VA:University Science Books.
Lowry DF, Hoyt DW, Khazi FA, Bagu J, Lindsey AG, Wilson DM III. 2003.
Investigation of the role of the histidine-aspartate pair in the human exonuclease
III-like abasic endonuclease, Ape1. J Mol Biol 329:311-322.
Ludwig DL, MacInnes MA, Takiguchi Y, Purtymun PE, Henrie M, Flannery M,
et al. 1998. A murine AP-endonuclease gene-targeted deficiency with post-implantation
embryonic progression and ionizing radiation sensitivity. Mutat Res 409:17-29.
Meira LB, Devaraj S, Kisby GE, Burns DK, Daniel RL, Hammer RE, et al.
2001. Heterozygosity for the mouse Apex gene results in phenotypes
associated with oxidative stress. Cancer Res 61:5552-5557.
Meplan C, Mann K, Hainaut P. 1999. Cadmium induces conformational modifications
of wild-type p53 and suppresses p53 response to DNA damage in cultured cells.
J Biol Chem 274:31663-31670.
Mol CD, Hosfield DJ, Tainer JA. 2000a. Abasic site recognition by two
apurinic/apyrimidinic endonuclease families in DNA base excision repair:
the 3' ends justify the means. Mutat Res 460:211-229.
Mol CD, Izumi T, Mitra S, Tainer JA. 2000b. DNA-bound structures and mutants
reveal abasic DNA binding by APE1 and DNA repair coordination. Nature 403:451-456.
Palecek E, Brazdova M, Cernocka H, Vlk D, Brazda V, Vojtesek B. 1999.
Effect of transition metals on binding of p53 protein to supercoiled DNA
and to consensus sequence in DNA fragments. Oncogene 18:3617-3625.
Petrat F, de Groot H, Sustmann R, Rauen U. 2002. The chelatable iron pool
in living cells: a methodically defined quantity. Biol Chem 383:489-502.
Porter DW, Yakushiji H, Nakabeppu Y, Sekiguchi M, Fivash MJ Jr, Kasprzak
KS. 1997. Sensitivity of Escherichia coli (MutT) and human (MTH1)
8-oxo-dGTPases to in vitro inhibition by the carcinogenic metals,
nickel(II), copper(II), cobalt(II) and cadmium(II). Carcinogenesis 18:1785-1791.
Roy NK, Rossman TG. 1992. Mutagenesis and comutagenesis by lead compounds.
Mutat Res 298:97-103.
Silbergeld EK. 2003. Facilitative mechanisms of lead as a carcinogen.
Mutat Res 533:121-133.
Suh D, Wilson DM III, Povirk LF. 1997. 3'-Phosphodiesterase activity of
human apurinic/apyrimidinic endonuclease at DNA double-strand break ends.
Nucleic Acids Res 25:2495-2500.
Waalkes MP. 2003. Cadmium carcinogenesis. Mutat Res 533:107-120.
Waisberg M, Joseph P, Hale B, Beyersmann D. 2003. Molecular and cellular
mechanisms of cadmium carcinogenesis. Toxicology 192:95-117.
Wilson DM III. 2003. Properties of and substrate determinants for the
exonuclease activity of human apurinic endonuclease Ape1. J Mol Biol 330:1027-1037.
Wilson DM III, Barsky D. 2001. The major human abasic endonuclease: formation,
consequences and repair of abasic lesions in DNA. Mutat Res 485:283-307.
Wilson DM III, Takeshita M, Grollman AP, Demple B. 1995. Incision activity
of human apurinic endonuclease (Ape) at abasic site analogs in DNA. J Biol
Chem 270:16002-16007.
Winters TA, Henner WD, Russell PS, McCullough A, Jorgensen TJ. 1994. Removal
of 3'-phosphoglycolate from DNA strand-break damage in an oligonucleotide
substrate by recombinant human apurinic/apyrimidinic endonuclease 1. Nucleic
Acids Res 22:1866-1873.
Xanthoudakis S, Smeyne RJ, Wallace JD, Curran T. 1996. The redox/DNA repair
protein, Ref-1, is essential for early embryonic development in mice. Proc
Natl Acad Sci USA 93:8919-8923.
Zharkov DO, Rosenquist TA. 2002. Inactivation of mammalian 8-oxoguanine-DNA
glycosylase by cadmium(II): implications for cadmium genotoxicity. DNA Repair
(Amst) 1:661-670.
Zheng W. 2001. Toxicology of choroid plexus: special reference to metal-induced
neurotoxicities. Microsc Res Tech 52:89-103.
Last Updated: May 6, 2004
|
|
 |
|
| |